Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: A population-based study of 327 patients

British Journal of Haematology

Volumn 160, Issue 2, 2013, Pages 251-254

  Bonicelli, Gilles ^a   Abdulkarim, Khadija ^b   Mounier, Morgane ^c   Johansson, Peter ^b   Rossi, Cédric ^a   Jooste, Valérie ^c   Andreasson, Björn ^b   Maynadié, Marc ^a,c   Girodon, François ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Epidemiology; Leukaemia; Polycythaemia vera; Risk factors; Survival

Indexed keywords

BUSULFAN; HYDROXYUREA; PHOSPHORUS; PIPOBROMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MORTALITY; MYELOFIBROSIS; OVERALL SURVIVAL; POLYCYTHEMIA VERA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL; THROMBOEMBOLISM; THROMBOSIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; NEOPLASMS; POLYCYTHEMIA VERA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SWEDEN; THROMBOSIS; YOUNG ADULT;

EID: 84872266376     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12117     Document Type: Article

References (15)

1. Abdulkarim, K., Ridell, B., Johansson, P., Kutti, J., Safai-Kutti, S. & Andreasson, B. (2010) The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. European Journal of Haematology, 86, 148-155.
2. Alvarez-Larran, A., Pereira, A., Cervantes, F., Arellano-Rodrigo, E., Hernandez-Boluda, J.C., Ferrer-Marin, F., Angona, A., Gomez, M., Muina, B., Guillen, H., Teruel, A., Bellosillo, B., Burgaleta, C., Vicente, V. & Besses, C. (2012) Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera. Blood, 119, 1363-1369.
3. Bjorkholm, M., Derolf, A.R., Hultcrantz, M., Kristinsson, S.Y., Ekstrand, C., Goldin, L.R., Andreasson, B., Birgegard, G., Linder, O., Malm, C., Markevarn, B., Nilsson, L., Samuelsson, J., Granath, F. & Landgren, O. (2011) Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms. Journal of Clinical Oncology, 29, 2410-2415.
4. Dickman, P.W., Sloggett, A., Hills, M. & Hakulinen, T. (2004) Regression models for relative survival. Statistics in Medicine, 23, 51-64.
5. Esteve, J., Benhamou, E., Croasdale, M. & Raymond, L. (1990) Relative survival and the estimation of net survival: elements for further discussion. Statistics in Medicine, 9, 529-538.
6. Finazzi, G., Caruso, V., Marchioli, R., Capnist, G., Chisesi, T., Finelli, C., Gugliotta, L., Landolfi, R., Kutti, J., Gisslinger, H., Marilus, R., Patrono, C., Pogliani, E.M., Randi, M.L., Villegas, A., Tognoni, G. & Barbui, T. (2005) Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood, 105, 2664-2670.
7. Frederiksen, H., Farkas, D.K., Christiansen, C.F., Hasselbalch, H.C. & Sorensen, H.T. (2011) Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood, 118, 6515-6520.
8. Gangat, N., Strand, J., Li, C.Y., Wu, W., Pardanani, A. & Tefferi, A. (2007) Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation. British Journal of Haematology, 138, 354-358.
9. Girodon, F., Bonicelli, G., Schaeffer, C., Mounier, M., Carillo, S., Lafon, I., Carli, P.M., Janoray, I., Ferrant, E. & Maynadie, M. (2009) Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica, 94, 865-869.
10. Hultcrantz, M., Kristinsson, S.Y., Andersson, T.M., Landgren, O., Eloranta, S., Derolf, A.R., Dickman, P.W. & Bjorkholm, M. (2012) Patterns of survival among patients with myeloproliferative neoplasms diagnosed in sweden from 1973 to 2008: a population-based study. Journal of Clinical Oncology, 30, 2995-3001.
11. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissues. World Health Organisation, Lyon, France.
12. Kiladjian, J.J., Chevret, S., Dosquet, C., Chomienne, C. & Rain, J.D. (2011) Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980. Journal of Clinical Oncology, 29, 3907-3913.
13. Maynadie, M., Girodon, F., Manivet-Janoray, I., Mounier, M., Mugneret, F., Bailly, F., Favre, B., Caillot, D., Petrella, T., Flesch, M. & Carli, P.M. (2011) Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica, 96, 55-61.
14. Passamonti, F., Rumi, E., Pietra, D., Elena, C., Boveri, E., Arcaini, L., Roncoroni, E., Astori, C., Merli, M., Boggi, S., Pascutto, C., Lazzarino, M. & Cazzola, M. (2010) A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia, 24, 1574-1579.
15. Tefferi, A., Rumi, E., Finazzi, G., Vannucchi, A.M., Randi, M., Nichele, I., Gisslinger, H., Vaidya, R., Cazzola, M., Rambaldi, A., Pieri, L., Rodeghiero, F., Bertozzi, I., Gisslinger, I., Pardanani, A., Thiele, J., Passamonti, F. & Barbui, T. (2011) Survival and prognosis among 1, 263 patients with polycythemia vera: an international study. Blood (ASH Annual Meeting Abstracts), 118, 127-128.